Patent holdings for IPC class C12N 15/113

Total number of patents in this class: 31140

10-year publication summary

1801
1974
2332
2339
2661
2754
2962
3171
3075
1711
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1178
781
The Regents of the University of California
20720
629
Ionis Pharmaceuticals, Inc.
955
628
University of Massachusetts
2313
430
Massachusetts Institute of Technology
10239
284
President and Fellows of Harvard College
6091
257
Regeneron Pharmaceuticals, Inc.
4698
245
Arrowhead Pharmaceuticals, Inc.
347
233
The Broad Institute, Inc.
1975
227
Inserm (institut National de La Sante et de La Recherche Medicale)
3337
206
The General Hospital Corporation
4858
203
The Board of Trustees of the Leland Stanford Junior University
6644
188
Centre National de La Recherche Scientifique
11016
182
Sarepta Therapeutics, Inc.
387
157
Monsanto Technology LLC
8570
156
Hoffmann-La Roche Inc.
3783
154
Institut National de La Sante et de La Recherche Medicale (inserm)
3219
152
The Trustees of the University of Pennsylvania
4414
147
Board of Regents, The University of Texas System
6102
142
Research Institute at Nationwide Children's Hospital
636
139
Other owners 25600